Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
ACR Open Rheumatology|June 1, 2021
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory ArthritidesGiovanni Adami, Maurizio Rossini, Ombretta Viapiana, et al.
Clinical and Experimental Rheumatology|December 11, 2023
Long-term effectiveness and predictors of bisphosphonate treatment in type I complex regional pain syndromeGiovanni Adami, Angelo Fassio, Maurizio Rossini, et al.
Nutrients|November 26, 2022
Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D DeficiencyAngelo Fassio, Davide Gatti, Maurizio Rossini, et al.
Clinical and Experimental Rheumatology|June 25, 2025
Bone mineral density is associated with pre-treatment pain levels of complex regional pain syndrome type 1 and predicts the response to N-containing bisphosphonatesVania Braga, Pietro Maistri, Davide Gatti, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 2, 2025
Romosozumab and Denosumab Combination Therapy After Denosumab in Postmenopausal OsteoporosisGiovanni Adami, Francesco Pollastri, Angelo Fassio, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 24, 2025
Radiofrequency Echographic Multi Spectrometry (REMS) for the evaluation of bone health in systemic lupus erythematosus (SLE)Mariana Diz Lopes, Giovanni Orsolini, Isotta Galvagni, et al.
Clinical and Experimental Rheumatology|March 4, 2026
Romosozumab effect on neutrophil-to-lymphocyte ratio in post-menopausal women at high risk of fractureMariana Diz-Lopes, Giorgia Scagliosi, Martina Teoni, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 13, 2025
ROMosozumab early experience in female patients with severe osteoporosis in an Italian real-world setting, the ROMEO studyGiovanni Adami, Marta Bartezaghi, Filippo Montanari, et al.
RMD Open|March 4, 2026
Bone properties and biomechanics in patients with psoriatic disease: a cross-sectional study with high-resolution peripheral quantitative CT (HRpQCT)Anna Piccinelli, Francesco Bellinato, Francesco Pollastri, et al.
JBMR Plus|September 24, 2025
Romosozumab in postmenopausal women with smoldering multiple myeloma: a prospective 12-mo studyMariana Diz Lopes, Francesco Pollastri, Francesca Mastropaolo, et al.
Pageof 4